Tiziana Life Sciences Ltd (NASDAQ:TLSA) said it will present at the Jefferies Global Healthcare Conference in New York on June 4, 2026.
CEO Ivor Elrifi and COO/CFO Keeren Shah will provide updates on the company’s clinical and corporate progress, including developments related to its lead candidate, intranasal foralumab.
The presentation is scheduled for 10:30am Eastern Time and will be followed by a Q&A session with institutional investors.